Increased placental XIAP and caspase 3 is associated with increased placental apoptosis in a baboon model of maternal nutrient reduction

Am J Obstet Gynecol. 2010 Oct;203(4):364.e13-8. doi: 10.1016/j.ajog.2010.05.021.

Abstract

Objective: Our objective was to determine signaling molecules and apoptosis rate in the term placenta of a baboon model of maternal nutrient reduction (MNR).

Study design: Female baboons were fed ad libitum for controls (n = 7) or 70% of control baboon diet (MNR; n = 6) from 30-165 days of gestation with necropsy at 165 days of gestation. Placental tissues were collected and fixed for immunohistochemistry or snap frozen to measure extracellular signal-regulated kinases, protein kinase B, JUN NH(2)-terminal kinase, X-linked inhibitor of apoptosis protein, and caspase 3. Placental villous apoptosis was determined by terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick-end labeling and cytokeratin 18 cleavage.

Results: Compared with the control placentas, MNR placentas demonstrated reduced placental weight (P < .02), decreased phospho (p)-ERK (P < .04), increased placental villous apoptosis (P < .001), increased villous cytokeratin 18 cleavage, increased X-linked inhibitor of apoptosis protein (P < .007), and increased active caspase 3 (P < .02).

Conclusion: We conclude that placental apoptosis is increased in this baboon model of MNR at term and that the increase in X-linked inhibitor of apoptosis protein may be a protective mechanism against this apoptosis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis*
  • Caspase 3 / metabolism*
  • Chorionic Villi / metabolism
  • Chorionic Villi / pathology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Female
  • Immunohistochemistry
  • Keratin-18 / metabolism
  • Models, Animal
  • Nutritional Status*
  • Organ Size
  • Papio
  • Placenta / metabolism*
  • Placenta / pathology*
  • Pregnancy
  • X-Linked Inhibitor of Apoptosis Protein / metabolism*

Substances

  • Keratin-18
  • X-Linked Inhibitor of Apoptosis Protein
  • Extracellular Signal-Regulated MAP Kinases
  • Caspase 3